Mark A. Downing

Toronto, ON, CA 
Toronto, ON, CA 

Overview

Mark Downing practices practicing medicine in Toronto, Canada.

His clinical expertise encompasses Sepsis, Strongyloidiasis, Severe Acute Respiratory Syndrome (SARS), and Rhabditida Infections.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Toronto, ON, Canada
Other Locations
Canada
Halifax, NS, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: Randomized Controlled Trial
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Other
Study Phase: Not Applicable
Medical Masks Versus N95 Respirators to Prevent 2019 Novel Coronavirus Disease (COVID-19) in Healthcare Workers: A Randomized Trial
Medical Masks Versus N95 Respirators to Prevent 2019 Novel Coronavirus Disease (COVID-19) in Healthcare Workers: A Randomized Trial
Enrollment Status: Completed
Publish Date: January 12, 2023
Intervention Type: Device
Study Phase: Phase 4
Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization Trial (EFFECT-CPE): a Multisite, Open-label, Randomized Controlled Feasibility Pilot Trial
Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization Trial (EFFECT-CPE): a Multisite, Open-label, Randomized Controlled Feasibility Pilot Trial
Enrollment Status: Suspended
Publish Date: November 03, 2022
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

29 Total Publications

Hospital characteristics associated with healthcare-associated viral respiratory infection rates in a Canadian acute care network.
Hospital characteristics associated with healthcare-associated viral respiratory infection rates in a Canadian acute care network.
Journal: Infection control and hospital epidemiology
Published: July 22, 2026

Frequently Asked Questions about Mark A. Downing

Is Mark A. Downing a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Mark A. Downing is classified as an Experienced expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark A. Downing participate in research or clinical trials?

Yes. Mark A. Downing has published 29 articles and abstracts on conditions like Sepsis. You can view a list of Mark A. Downing's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Downing's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile